Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Defective angiogenesis in CXCL12 mutant mice impairs skeletal muscle regeneration.

Hardy D, Fefeu M, Besnard A, Briand D, Gasse P, Arenzana-Seisdedos F, Rocheteau P, Chrétien F.

Skelet Muscle. 2019 Sep 18;9(1):25. doi: 10.1186/s13395-019-0210-5.

2.

CCR5 structural plasticity shapes HIV-1 phenotypic properties.

Colin P, Zhou Z, Staropoli I, Garcia-Perez J, Gasser R, Armani-Tourret M, Benureau Y, Gonzalez N, Jin J, Connell BJ, Raymond S, Delobel P, Izopet J, Lortat-Jacob H, Alcami J, Arenzana-Seisdedos F, Brelot A, Lagane B.

PLoS Pathog. 2018 Dec 6;14(12):e1007432. doi: 10.1371/journal.ppat.1007432. eCollection 2018 Dec.

3.

Identification of a new subset of lymph node stromal cells involved in regulating plasma cell homeostasis.

Huang HY, Rivas-Caicedo A, Renevey F, Cannelle H, Peranzoni E, Scarpellino L, Hardie DL, Pommier A, Schaeuble K, Favre S, Vogt TK, Arenzana-Seisdedos F, Schneider P, Buckley CD, Donnadieu E, Luther SA.

Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):E6826-E6835. doi: 10.1073/pnas.1712628115. Epub 2018 Jul 2.

4.

CCR5 adopts three homodimeric conformations that control cell surface delivery.

Jin J, Momboisse F, Boncompain G, Koensgen F, Zhou Z, Cordeiro N, Arenzana-Seisdedos F, Perez F, Lagane B, Kellenberger E, Brelot A.

Sci Signal. 2018 May 8;11(529). pii: eaal2869. doi: 10.1126/scisignal.aal2869.

PMID:
29739880
5.

Suramin interacts with the positively charged region surrounding the 5-fold axis of the EV-A71 capsid and inhibits multiple enterovirus A.

Ren P, Zheng Y, Wang W, Hong L, Delpeyroux F, Arenzana-Seisdedos F, Altmeyer R.

Sci Rep. 2017 Feb 20;7:42902. doi: 10.1038/srep42902.

6.

Essential role of immobilized chemokine CXCL12 in the regulation of the humoral immune response.

Barinov A, Luo L, Gasse P, Meas-Yedid V, Donnadieu E, Arenzana-Seisdedos F, Vieira P.

Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2319-2324. doi: 10.1073/pnas.1611958114. Epub 2017 Feb 13.

7.

Heparan sulfate differentially controls CXCL12α- and CXCL12γ-mediated cell migration through differential presentation to their receptor CXCR4.

Connell BJ, Sadir R, Baleux F, Laguri C, Kleman JP, Luo L, Arenzana-Seisdedos F, Lortat-Jacob H.

Sci Signal. 2016 Nov 1;9(452):ra107.

PMID:
27803285
8.

Guidelines for cloning, expression, purification and functional characterization of primary HIV-1 envelope glycoproteins.

Benureau Y, Colin P, Staropoli I, Gonzalez N, Garcia-Perez J, Alcami J, Arenzana-Seisdedos F, Lagane B.

J Virol Methods. 2016 Oct;236:184-195. doi: 10.1016/j.jviromet.2016.07.019. Epub 2016 Jul 20.

PMID:
27451265
9.

Public T cell receptors confer high-avidity CD4 responses to HIV controllers.

Benati D, Galperin M, Lambotte O, Gras S, Lim A, Mukhopadhyay M, Nouël A, Campbell KA, Lemercier B, Claireaux M, Hendou S, Lechat P, de Truchis P, Boufassa F, Rossjohn J, Delfraissy JF, Arenzana-Seisdedos F, Chakrabarti LA.

J Clin Invest. 2016 Jun 1;126(6):2093-108. doi: 10.1172/JCI83792. Epub 2016 Apr 25.

10.

Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.

Fernandez-Garcia MD, Meertens L, Chazal M, Hafirassou ML, Dejarnac O, Zamborlini A, Despres P, Sauvonnet N, Arenzana-Seisdedos F, Jouvenet N, Amara A.

MBio. 2016 Feb 9;7(1):e01956-15. doi: 10.1128/mBio.01956-15.

11.

The sweet spot: how GAGs help chemokines guide migrating cells.

Monneau Y, Arenzana-Seisdedos F, Lortat-Jacob H.

J Leukoc Biol. 2016 Jun;99(6):935-53. doi: 10.1189/jlb.3MR0915-440R. Epub 2015 Dec 23. Review.

PMID:
26701132
12.

SDF-1/CXCL12: A Chemokine in the Life Cycle of HIV.

Arenzana-Seisdedos F.

Front Immunol. 2015 Jun 5;6:256. doi: 10.3389/fimmu.2015.00256. eCollection 2015. Review. No abstract available.

13.

A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity.

Garcia-Perez J, Staropoli I, Azoulay S, Heinrich JT, Cascajero A, Colin P, Lortat-Jacob H, Arenzana-Seisdedos F, Alcami J, Kellenberger E, Lagane B.

Retrovirology. 2015 Jun 18;12:50. doi: 10.1186/s12977-015-0177-1.

14.

The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo.

Ren P, Zou G, Bailly B, Xu S, Zeng M, Chen X, Shen L, Zhang Y, Guillon P, Arenzana-Seisdedos F, Buchy P, Li J, von Itzstein M, Li Q, Altmeyer R.

Emerg Microbes Infect. 2014 Sep;3(9):e62. doi: 10.1038/emi.2014.60. Epub 2014 Sep 3.

15.

Recognition determinants of broadly neutralizing human antibodies against dengue viruses.

Rouvinski A, Guardado-Calvo P, Barba-Spaeth G, Duquerroy S, Vaney MC, Kikuti CM, Navarro Sanchez ME, Dejnirattisai W, Wongwiwat W, Haouz A, Girard-Blanc C, Petres S, Shepard WE, Desprès P, Arenzana-Seisdedos F, Dussart P, Mongkolsapaya J, Screaton GR, Rey FA.

Nature. 2015 Apr 2;520(7545):109-13. doi: 10.1038/nature14130. Epub 2015 Jan 12.

16.

Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.

Jin J, Colin P, Staropoli I, Lima-Fernandes E, Ferret C, Demir A, Rogée S, Hartley O, Randriamampita C, Scott MG, Marullo S, Sauvonnet N, Arenzana-Seisdedos F, Lagane B, Brelot A.

J Biol Chem. 2014 Jul 4;289(27):19042-52. doi: 10.1074/jbc.M114.559831. Epub 2014 May 22.

17.

HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines.

Colin P, Bénureau Y, Staropoli I, Wang Y, Gonzalez N, Alcami J, Hartley O, Brelot A, Arenzana-Seisdedos F, Lagane B.

Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9475-80. doi: 10.1073/pnas.1222205110. Epub 2013 May 21.

18.

β-arrestin-dependent activation of the cofilin pathway is required for the scavenging activity of the atypical chemokine receptor D6.

Borroni EM, Cancellieri C, Vacchini A, Benureau Y, Lagane B, Bachelerie F, Arenzana-Seisdedos F, Mizuno K, Mantovani A, Bonecchi R, Locati M.

Sci Signal. 2013 Apr 30;6(273):ra30.1-11, S1-3. doi: 10.1126/scisignal.2003627. Erratum in: Sci Signal. 2013 Aug 13;6(288):er5.

PMID:
23633677
19.

Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions.

Rueda P, Richart A, Récalde A, Gasse P, Vilar J, Guérin C, Lortat-Jacob H, Vieira P, Baleux F, Chretien F, Arenzana-Seisdedos F, Silvestre JS.

Circulation. 2012 Oct 9;126(15):1882-95. doi: 10.1161/CIRCULATIONAHA.112.113290. Epub 2012 Oct 3.

20.

Complementary methods provide evidence for the expression of CXCR7 on human B cells.

Humpert ML, Tzouros M, Thelen S, Bignon A, Levoye A, Arenzana-Seisdedos F, Balabanian K, Bachelerie F, Langen H, Thelen M.

Proteomics. 2012 Jun;12(12):1938-48. doi: 10.1002/pmic.201100581.

PMID:
22623068
21.

Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses.

Viejo-Borbolla A, Martinez-Martín N, Nel HJ, Rueda P, Martín R, Blanco S, Arenzana-Seisdedos F, Thelen M, Fallon PG, Alcamí A.

PLoS Pathog. 2012 Feb;8(2):e1002497. doi: 10.1371/journal.ppat.1002497. Epub 2012 Feb 2.

22.

Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody.

Cockburn JJ, Navarro Sanchez ME, Fretes N, Urvoas A, Staropoli I, Kikuti CM, Coffey LL, Arenzana Seisdedos F, Bedouelle H, Rey FA.

Structure. 2012 Feb 8;20(2):303-14. doi: 10.1016/j.str.2012.01.001. Epub 2012 Jan 26.

23.

C/EBP homologous protein-10 (CHOP-10) limits postnatal neovascularization through control of endothelial nitric oxide synthase gene expression.

Loinard C, Zouggari Y, Rueda P, Ramkhelawon B, Cochain C, Vilar J, Récalde A, Richart A, Charue D, Duriez M, Mori M, Arenzana-Seisdedos F, Lévy BI, Heymes C, Silvestre JS.

Circulation. 2012 Feb 28;125(8):1014-26. doi: 10.1161/CIRCULATIONAHA.111.041830. Epub 2012 Jan 20.

PMID:
22265908
24.

ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation.

Werneke SW, Schilte C, Rohatgi A, Monte KJ, Michault A, Arenzana-Seisdedos F, Vanlandingham DL, Higgs S, Fontanet A, Albert ML, Lenschow DJ.

PLoS Pathog. 2011 Oct;7(10):e1002322. doi: 10.1371/journal.ppat.1002322. Epub 2011 Oct 20.

25.

Semen clusterin is a novel DC-SIGN ligand.

Sabatte J, Faigle W, Ceballos A, Morelle W, Rodríguez Rodrígues C, Remes Lenicov F, Thépaut M, Fieschi F, Malchiodi E, Fernández M, Arenzana-Seisdedos F, Lortat-Jacob H, Michalski JC, Geffner J, Amigorena S.

J Immunol. 2011 Nov 15;187(10):5299-309. doi: 10.4049/jimmunol.1101889. Epub 2011 Oct 17.

26.

CXCL12γ isoform is expressed on endothelial and dendritic cells in rheumatoid arthritis synovium and regulates T cell activation.

Santiago B, Izquierdo E, Rueda P, Del Rey MJ, Criado G, Usategui A, Arenzana-Seisdedos F, Pablos JL.

Arthritis Rheum. 2012 Feb;64(2):409-17. doi: 10.1002/art.33345.

27.

Allosteric model of maraviroc binding to CC chemokine receptor 5 (CCR5).

Garcia-Perez J, Rueda P, Alcami J, Rognan D, Arenzana-Seisdedos F, Lagane B, Kellenberger E.

J Biol Chem. 2011 Sep 23;286(38):33409-21. doi: 10.1074/jbc.M111.279596. Epub 2011 Jul 20.

28.

CXCL12 expression by healthy and malignant ovarian epithelial cells.

Machelon V, Gaudin F, Camilleri-Broët S, Nasreddine S, Bouchet-Delbos L, Pujade-Lauraine E, Alexandre J, Gladieff L, Arenzana-Seisdedos F, Emilie D, Prévot S, Broët P, Balabanian K.

BMC Cancer. 2011 Mar 16;11:97. doi: 10.1186/1471-2407-11-97.

29.

Appraising the roles of CBLL1 and the ubiquitin/proteasome system for flavivirus entry and replication.

Fernandez-Garcia MD, Meertens L, Bonazzi M, Cossart P, Arenzana-Seisdedos F, Amara A.

J Virol. 2011 Mar;85(6):2980-9. doi: 10.1128/JVI.02483-10. Epub 2010 Dec 29.

30.

A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: clues to understanding HPV-pathogenesis in WHIM syndrome.

Chow KY, Brotin É, Ben Khalifa Y, Carthagena L, Teissier S, Danckaert A, Galzi JL, Arenzana-Seisdedos F, Thierry F, Bachelerie F.

Cell Host Microbe. 2010 Dec 16;8(6):523-33. doi: 10.1016/j.chom.2010.11.006.

31.

New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection.

Garcia-Perez J, Rueda P, Staropoli I, Kellenberger E, Alcami J, Arenzana-Seisdedos F, Lagane B.

J Biol Chem. 2011 Feb 18;286(7):4978-90. doi: 10.1074/jbc.M110.168955. Epub 2010 Nov 30.

32.

SDF-1/CXCL12 production by mature dendritic cells inhibits the propagation of X4-tropic HIV-1 isolates at the dendritic cell-T-cell infectious synapse.

González N, Bermejo M, Calonge E, Jolly C, Arenzana-Seisdedos F, Pablos JL, Sattentau QJ, Alcamí J.

J Virol. 2010 May;84(9):4341-51. doi: 10.1128/JVI.02449-09. Epub 2010 Feb 24.

33.

Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.

Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, Guivel-Benhassine F, Kraxner A, Tschopp J, Higgs S, Michault A, Arenzana-Seisdedos F, Colonna M, Peduto L, Schwartz O, Lecuit M, Albert ML.

J Exp Med. 2010 Feb 15;207(2):429-42. doi: 10.1084/jem.20090851. Epub 2010 Feb 1.

34.

Idiopathic CD4+ T-cell lymphocytopenia is associated with impaired membrane expression of the chemokine receptor CXCR4.

Scott-Algara D, Balabanian K, Chakrabarti LA, Mouthon L, Dromer F, Didier C, Arenzana-Seisdedos F, Lortholary O.

Blood. 2010 May 6;115(18):3708-17. doi: 10.1182/blood-2009-02-202796. Epub 2009 Dec 28.

PMID:
20038787
35.

A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry.

Baleux F, Loureiro-Morais L, Hersant Y, Clayette P, Arenzana-Seisdedos F, Bonnaffé D, Lortat-Jacob H.

Nat Chem Biol. 2009 Oct;5(10):743-8. doi: 10.1038/nchembio.207. Epub 2009 Sep 6.

PMID:
19734912
36.

Developmental expression profile of the CXCL12gamma isoform: insights into its tissue-specific role.

Franco D, Rueda P, Lendínez E, Arenzana-Seisdedos F, Caruz A.

Anat Rec (Hoboken). 2009 Jun;292(6):891-901. doi: 10.1002/ar.20899.

37.

[Viral entry as therapeutic target. Current situation of entry inhibitors].

Arenzana-Seisdedos F.

Enferm Infecc Microbiol Clin. 2008 Oct;26 Suppl 11:5-11. Review. Spanish.

PMID:
19133215
38.

The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins.

Rueda P, Balabanian K, Lagane B, Staropoli I, Chow K, Levoye A, Laguri C, Sadir R, Delaunay T, Izquierdo E, Pablos JL, Lendinez E, Caruz A, Franco D, Baleux F, Lortat-Jacob H, Arenzana-Seisdedos F.

PLoS One. 2008 Jul 2;3(7):e2543. doi: 10.1371/journal.pone.0002543.

39.

Small neutralizing molecules to inhibit actions of the chemokine CXCL12.

Hachet-Haas M, Balabanian K, Rohmer F, Pons F, Franchet C, Lecat S, Chow KY, Dagher R, Gizzi P, Didier B, Lagane B, Kellenberger E, Bonnet D, Baleux F, Haiech J, Parmentier M, Frossard N, Arenzana-Seisdedos F, Hibert M, Galzi JL.

J Biol Chem. 2008 Aug 22;283(34):23189-99. doi: 10.1074/jbc.M803947200. Epub 2008 Jun 13.

40.

CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome.

Lagane B, Chow KY, Balabanian K, Levoye A, Harriague J, Planchenault T, Baleux F, Gunera-Saad N, Arenzana-Seisdedos F, Bachelerie F.

Blood. 2008 Jul 1;112(1):34-44. doi: 10.1182/blood-2007-07-102103. Epub 2008 Apr 24.

41.

Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion.

Gérardin P, Barau G, Michault A, Bintner M, Randrianaivo H, Choker G, Lenglet Y, Touret Y, Bouveret A, Grivard P, Le Roux K, Blanc S, Schuffenecker I, Couderc T, Arenzana-Seisdedos F, Lecuit M, Robillard PY.

PLoS Med. 2008 Mar 18;5(3):e60. doi: 10.1371/journal.pmed.0050060.

42.

Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example.

Laguri C, Arenzana-Seisdedos F, Lortat-Jacob H.

Carbohydr Res. 2008 Aug 11;343(12):2018-23. doi: 10.1016/j.carres.2008.01.047. Epub 2008 Feb 20. Review.

PMID:
18334249
43.

A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease.

Couderc T, Chrétien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Desprès P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M.

PLoS Pathog. 2008 Feb 8;4(2):e29. doi: 10.1371/journal.ppat.0040029.

44.

Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling.

Balabanian K, Levoye A, Klemm L, Lagane B, Hermine O, Harriague J, Baleux F, Arenzana-Seisdedos F, Bachelerie F.

J Clin Invest. 2008 Mar;118(3):1074-84. doi: 10.1172/JCI33187.

45.

An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain.

Ruiz-Argüello MB, Smith VP, Campanella GS, Baleux F, Arenzana-Seisdedos F, Luster AD, Alcami A.

J Virol. 2008 Jan;82(2):917-26. Epub 2007 Nov 14.

46.

The novel CXCL12gamma isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4.

Laguri C, Sadir R, Rueda P, Baleux F, Gans P, Arenzana-Seisdedos F, Lortat-Jacob H.

PLoS One. 2007 Oct 31;2(10):e1110.

47.

Characterization of reemerging chikungunya virus.

Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, Rudnicka D, Sol-Foulon N, Le Roux K, Prevost MC, Fsihi H, Frenkiel MP, Blanchet F, Afonso PV, Ceccaldi PE, Ozden S, Gessain A, Schuffenecker I, Verhasselt B, Zamborlini A, Saïb A, Rey FA, Arenzana-Seisdedos F, Desprès P, Michault A, Albert ML, Schwartz O.

PLoS Pathog. 2007 Jun;3(6):e89.

48.

Long oligonucleotide microarrays for African green monkey gene expression profile analysis.

Jacquelin B, Mayau V, Brysbaert G, Regnault B, Diop OM, Arenzana-Seisdedos F, Rogge L, Coppée JY, Barré-Sinoussi F, Benecke A, Müller-Trutwin MC.

FASEB J. 2007 Oct;21(12):3262-71. Epub 2007 May 16.

PMID:
17507667
49.

Rapid hematopoietic progenitor mobilization by sulfated colominic acid.

Kubonishi S, Kikuchi T, Yamaguchi S, Tamamura H, Fujii N, Watanabe T, Arenzana-Seisdedos F, Ikeda K, Matsui T, Tanimoto M, Katayama Y.

Biochem Biophys Res Commun. 2007 Apr 20;355(4):970-5. Epub 2007 Feb 22.

PMID:
17335773
50.

CD4 and CCR5 constitutively interact at the plasma membrane of living cells: a confocal fluorescence resonance energy transfer-based approach.

Gaibelet G, Planchenault T, Mazères S, Dumas F, Arenzana-Seisdedos F, Lopez A, Lagane B, Bachelerie F.

J Biol Chem. 2006 Dec 8;281(49):37921-9. Epub 2006 Oct 11.

Supplemental Content

Loading ...
Support Center